Obesity is on the rise and hard to treat. Whenever possible, you, your patient, and the family should face the problem early and deal with it before it assumes awesome proportions. For a moderately obese child, not gaining for a while may be all that's needed.
Dupilumab (Dupixent) becomes first FDA-approved drug for adolescent CRSwNP
September 13th 2024The landmark indication is supported by a couple of pivotal trials assessing dupilumab for patients with chronic rhinosinusitis with nasal polyps, as well as a pediatric severe asthma trial assessing the biologic.